ZA200005189B - Stable dosage forms of fluoxetine and its enantiomers. - Google Patents
Stable dosage forms of fluoxetine and its enantiomers.Info
- Publication number
- ZA200005189B ZA200005189B ZA200005189A ZA200005189A ZA200005189B ZA 200005189 B ZA200005189 B ZA 200005189B ZA 200005189 A ZA200005189 A ZA 200005189A ZA 200005189 A ZA200005189 A ZA 200005189A ZA 200005189 B ZA200005189 B ZA 200005189B
- Authority
- ZA
- South Africa
- Prior art keywords
- fluoxetine
- enantiomers
- dosage forms
- stable dosage
- stable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/049,227 US20030013740A1 (en) | 1998-03-27 | 1998-03-27 | Stable dosage forms of fluoxetine and its enantiomers |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200005189B true ZA200005189B (en) | 2001-05-22 |
Family
ID=21958714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200005189A ZA200005189B (en) | 1998-03-27 | 2000-09-27 | Stable dosage forms of fluoxetine and its enantiomers. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20030013740A1 (xx) |
EP (1) | EP1067918A1 (xx) |
JP (1) | JP2002509882A (xx) |
KR (1) | KR20010034703A (xx) |
CN (1) | CN1303280A (xx) |
AU (1) | AU3205399A (xx) |
BR (1) | BR9909118A (xx) |
CA (1) | CA2325858A1 (xx) |
NO (1) | NO20004818L (xx) |
WO (1) | WO1999049857A1 (xx) |
ZA (1) | ZA200005189B (xx) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6372919B1 (en) * | 2001-01-11 | 2002-04-16 | Dov Pharmaceutical, Inc. | (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent |
US6310251B1 (en) | 2001-01-31 | 2001-10-30 | Grayson Walker Stowell | Form a of fluoxetine hydrochloride |
US6310250B1 (en) | 2001-01-31 | 2001-10-30 | Grayson Walker Stowell | Form A of fluoxetine hydrochloride |
US6316672B1 (en) | 2001-01-31 | 2001-11-13 | Grayson Walker Stowell | Form a of fluoxetine hydrochloride |
US6313350B1 (en) | 2001-01-31 | 2001-11-06 | Grayson Walker Stowell | Form a of fluoxetine hydrochloride |
US6258853B1 (en) | 2001-01-31 | 2001-07-10 | Grayson Walker Stowell | Form a of fluoxetine hydrochloride |
US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
US20080045725A1 (en) | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
NZ619413A (en) | 2006-05-04 | 2015-08-28 | Boehringer Ingelheim Int | Polymorphs of a dpp-iv enzyme inhibitor |
AR071175A1 (es) | 2008-04-03 | 2010-06-02 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
WO2010094471A1 (en) | 2009-02-17 | 2010-08-26 | Krka, D. D., Novo Mesto | Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
JP5952912B2 (ja) | 2011-12-15 | 2016-07-13 | アルカーメス ファーマ アイルランド リミテッド | 二級アミン化合物のプロドラッグ |
MX2015016589A (es) * | 2015-12-02 | 2017-06-01 | Samuel CHAIT AUERBACH Jaime | Composicion oral veterinaria con gabapentina. |
CN107334744B (zh) * | 2017-07-24 | 2020-09-04 | 湖南洞庭药业股份有限公司 | 盐酸美金刚药物组合物和制法 |
CN107334742B (zh) * | 2017-08-18 | 2020-01-31 | 山东力诺制药有限公司 | 一种盐酸氟西汀分散片及其制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4594358A (en) * | 1985-02-25 | 1986-06-10 | Eli Lilly And Company | Analgesic method |
CH678920A5 (xx) * | 1989-11-14 | 1991-11-29 | Gergely Gerhard | |
CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
DE69728857T3 (de) * | 1996-02-09 | 2010-02-18 | Quadrant Drug Delivery Ltd., Ruddington | Feste arzneimittel enthaltend trehalose |
EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
CA2175939C (en) * | 1996-05-07 | 1999-09-14 | Michael Warnett Hetherington | Manual capsule filling device |
ES2227707T3 (es) * | 1996-07-15 | 2005-04-01 | Alza Corporation | Nuevas formulaciones para la administracion transdermica de acetato de fluoxetina y de maleato de fluoxetina. |
US5830500A (en) * | 1996-07-22 | 1998-11-03 | Pentech Pharmaceuticals, Inc. | Low dose fluoxetine tablet |
-
1998
- 1998-03-27 US US09/049,227 patent/US20030013740A1/en not_active Abandoned
-
1999
- 1999-03-25 CA CA002325858A patent/CA2325858A1/en not_active Abandoned
- 1999-03-25 EP EP99914151A patent/EP1067918A1/en not_active Withdrawn
- 1999-03-25 JP JP2000540823A patent/JP2002509882A/ja active Pending
- 1999-03-25 KR KR1020007010708A patent/KR20010034703A/ko not_active Application Discontinuation
- 1999-03-25 WO PCT/US1999/006601 patent/WO1999049857A1/en not_active Application Discontinuation
- 1999-03-25 BR BR9909118-6A patent/BR9909118A/pt not_active IP Right Cessation
- 1999-03-25 AU AU32053/99A patent/AU3205399A/en not_active Abandoned
- 1999-03-25 CN CN99806619A patent/CN1303280A/zh active Pending
-
2000
- 2000-09-26 NO NO20004818A patent/NO20004818L/no unknown
- 2000-09-27 ZA ZA200005189A patent/ZA200005189B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1067918A1 (en) | 2001-01-17 |
CA2325858A1 (en) | 1999-10-07 |
WO1999049857A1 (en) | 1999-10-07 |
BR9909118A (pt) | 2001-10-16 |
AU3205399A (en) | 1999-10-18 |
JP2002509882A (ja) | 2002-04-02 |
US20030013740A1 (en) | 2003-01-16 |
KR20010034703A (ko) | 2001-04-25 |
NO20004818D0 (no) | 2000-09-26 |
CN1303280A (zh) | 2001-07-11 |
NO20004818L (no) | 2000-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200005189B (en) | Stable dosage forms of fluoxetine and its enantiomers. | |
ZA200110022B (en) | Thiazoloderivatives and pharmaceutical compositions containing them. | |
ZA991951B (en) | Compound and its use. | |
ZA200003392B (en) | Cutting elements and methods of manufacture thereof. | |
ZA200107870B (en) | Fused-ring compounds and use thereof. | |
HK1049630A1 (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same. | |
ZA200203316B (en) | New use and novel n-azabicyclo-amide derivatives. | |
ZA99454B (en) | Novel dosage form. | |
HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
MXPA01012104A (es) | Electrocatalizador de rodio y metodos de preparacion. | |
EP1112252A4 (en) | KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF | |
PL351250A1 (en) | Antipicornaviral compounds, their preparation and use | |
IL143221A0 (en) | Combination of cerivastatin and fibrates | |
HK1048318B (zh) | 取代的3-苯基-5-烷氧基-1,3,4-噁二唑-2-酮及其作為脂酶抑制劑的用途 | |
ZA991232B (en) | New compound and pharmaceutical compositions thereof. | |
ZA200006020B (en) | Voacamine as anti-malarial agent and anti-malarial agent containing voacamine. | |
ZA985709B (en) | Encapsulated solution dosage forms of sertraline. | |
HUP0104723A3 (en) | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use | |
ZA200109120B (en) | Use of Arylalkanoylpyridazines. | |
HUP0103006A3 (en) | Substituted betha-diketones, pharmaceutical compositions containing them and their use | |
ZA99835B (en) | Preparation of microballoons. | |
GB9805464D0 (en) | Construction of ioniser | |
ZA200110325B (en) | Highly selective norepinephrine reuptake inhibitors and methods of using the same. | |
ZA995435B (en) | Prestressing of supports. | |
EG23239A (en) | Preparation of haemagel. |